Nurix Therapeutics, Inc.
NRIXHealthcareBiotechnology
市值
$2.08B
CEO
Arthur T. Sands
员工数
314
行业
Biotechnology
上市日期
2020-07-24
收录人数
13
近期高管变动
11/10上任Roger Dansey, M.D. Director of the Company and Member of the Clinical and Commercialization Committee of the Board08/22resignedLori A. Kunkel, M.D. Class III director of the Board, chair of the Clinical and Commercialization Committee, member of the Clinical and Commercialization Committee and the Compensation Committee of the Board08/22上任Roy D. Baynes, MB.Bch., M.Med., Ph.D. chair of the Clinical and Commercialization Committee of the Board03/13上任Roy D. Baynes, MB.Bch., M.Med., Ph.D. director of the Company and member of the Clinical and Commercialization Committee of the Board10/16上任Anil Kapur director of the Company and member of the Development Advisory Committee of the Board04/10resignedStefani A. Wolff Chief Operating Officer and Executive Vice President of Product Development09/14上任Edward C. Saltzman Director of the Company, Member of the Compensation Committee of the Board, Member of the Development Advisory Committee of the Board
A
Arthur Sands
President, CEO
董事高管
C
Christine Ring
Chief Legal Officer
高管
G
Gwenn Hansen
Chief Scientific Officer
高管
H
Houte Van
Chief Financial Officer
高管